Gillson Longenbaugh Foundation

EIN 760001952

Houston, TX 77027 |(713) 439-5739

Total Given 2017–2021
$21.5M
51 grants · $4.3M avg/year
based on 5 yrs of IRS 990-PF records on file
$1M+/yr
mid-tier
capacity
$25K
typical mid grants · $10K–$162K
grant size
44%
supporter · 14/32 multi-year
repeat
$37.3M
Assets (2019)
32
Distinct Recipients

About

The following information is submitted in accordance with Treasury RegulationSection 1.6043-3(a)(1) and the Form 990-PF instructions:The Foundation made distributions of cash to the grantee listed in the attachment to Part XV, Line 3a; each such grant was made solely for the charitable purpose listed on the schedule. The Foundation has terminated under Section 507(b)(1)(A) by distributing its remaining net assets to a Section 509(a)(1) public charity. The final distribution was made to the grantee reported in Part XV, Line 3a as of 5/31/2021.

Focus Areas

Health Science & Research

Application Information

Accepts Unsolicited Proposals No — Preselected Only
Contact Person Vanguard Charitable Endowment
Phone (713) 439-5739

Financial Trends

Giving Over Time

Total Assets Over Time

View financial data as table
YearTotal GivingTotal AssetsRevenueGrants
2017 $2.8M $38.5M $2.0M 11
2018 $3.3M $40.3M $4.4M 20
2019 $3.4M $37.3M $1.2M 19
2021 $12.0M $0 $208K 1

Grant Size Distribution

Based on 51 grants on record

Minimum
$2K
25th Pctl
$10K
Median
$25K
Average
$421K
75th Pctl
$162K
Maximum
$12.0M

Geographic Distribution


Texas Counties Served

86.3% of US grants · Rank #1 of 7 states $20.8M across 44 grants 4 of 254 counties

Top 4 counties

  1. 1 Harris 36 grants · $20.2M
  2. 2 Galveston 2 grants · $445K
  3. 3 Travis 5 grants · $55K
  4. 4 Waller 1 grant · $20K

Officers & Directors

Grants Awarded (51 total)

Purpose
Vanguard Charitable Endowment Houston, TX $11,985,897 Cancer research, other medical research, and other charitable purposes 2021
Vanguard Charitable Endowment Progr Houston, TX $2,500,000 Cancer and other medical research 2017
Vanguard Charitable Endowment Houston, TX $2,000,000 Cancer and other medical research 2019
Vanguard Charitable Endowment Progr Houston, TX $1,900,000 Cancer and other medical research 2018
Rutgers Cancer Institute of New Jer New Brunswick, NJ $250,000 General support 2018
University of Texas Medical Branch Galveston, TX $225,000 Research and clinical studies 2019
University of Texas Medical Branch Galveston, TX $220,000 Cancer and other medical research 2018
Baylor College of Medicine Houston, TX $207,000 General support 2019
University of Michigan Ann Arbor, MI $200,000 Tumor immunology program 2018
University of Michigan Ann Arbor, MI $200,000 Research and clinical studies 2019
Texas Childrens Hospital Houston, TX $172,500 General Support 2019
Institute for Rehabilition Research Houston, TX $165,000 Research 2018
TIRR Foundation Houston, TX $165,000 Mission Connect program 2019
University of Houston Houston, TX $160,000 General support 2018
Univ of Texas MD Anderson Cancer Ct Houston, TX $150,000 Research and clinical studies 2019
Crime Stoppers of Houston Inc Houston, TX $101,500 Capital campaign, Safe School Institute, and Safe Community Program 2018
Methodist Hospital Foundation Houston, TX $100,000 Alzheimers drug screening and repositioning 2017
Methodist Hospital Foundation Houston, TX $100,000 Alzheimers drug screening and repositioning 2018
Univ of Texas MD Anderson Cancer Ct Houston, TX $86,000 Investigation into the biology, mechanisms, and therapeutic implications of intracrine VEGF signaling in human CRC cells 2017
University of Texas Health Science Houston, TX $51,425 UT Health's "Association of Dementia and Concussion in Elderly" 2019
Texas Childrens Hospital Houston, TX $50,000 David Poplack Research Award 2019
Texas Childrens Hospital Houston, TX $50,000 Lester & Sue Smith Rising Star Research Award 2019
Harris County Houston, TX $48,000 Public purposes 2018
University of Texas Health Science Houston, TX $46,000 UT Health's "Molecular Basis of Infectious Diseases/Microbiology and Molecular Genetics (MBID/MMG) Summer... 2018
University of New Mexico Foundation Albuquerque, NM $45,000 Indentification and development of theraputically effective recombinant monoclonal human anti-tumor antibodies 2017